Upper airway surgery should not be first line treatment for obstructive sleep apnoea in adults by Elshaug, A. et al.
CHANGE PAGE
Upper airway surgery should not be first line treatment for
obstructive sleep apnoea in adults
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The clinical problem
The prevalence of obstructive sleep apnoea in high
income countries is estimated to be 20% for mild
disease and 6-7% for moderate or severe disease. The
condition is associated with multiple morbidities,
motor vehicle crashes, and reduced health related
quality of life.1 Clinical guidelines recommend con-
tinuous positive airway pressure (CPAP) with weight
and alcohol management (if indicated) as first line
treatment for symptomatic, moderate to severe
obstructive sleep apnoea.2 3 Upper airway surgery
(such as uvulopalatopharyngoplasty) may also be
done, but evidence does not support its use.4 However,
use of surgical procedures iswidespreadand increasing
in Australia and elsewhere (such as the Nordic
countries).5 6 We propose that upper airway surgery
should not be first line treatment for obstructive sleep
apnoea in adults.
The evidence for change
An array of surgical procedures is used either
concurrently or stepwise over multiple operations. A
recent multicentre retrospective audit revealed sub-
stantial procedural variability; the observed cohort
(n=94) received 41 varying combinations of surgical
procedures.5 In a Cochrane review of seven rando-
mised controlled trials (n=412) in 2005, the results of
surgery were inconsistent: significant improvement in
polysomnography occurred in only three trials (com-
bined n=225), and health related quality of life
improved in only four trials (combined n=138).4
Comments on the clinical significance of both these
measures were limited, and the review concluded that
surgeryhad a lack of an impact on symptoms (except in
two trials) and that overall significant benefit was not
shown.4 Even where improvements in quality of life
havebeenshown immediately after surgery, thesewere
rarely sustained beyond 12-24 months.24 6
A recent systematic review of 48 studies (4 rando-
mised controlled trials, 17 prospective studies of
various designs, 23 retrospective case series, 4 unspe-
cified design) found that up to 62% of 21 346 patients
who had surgery reported persistent adverse effects,6
such as persistent dry throat, globus sensation,
difficulty in swallowing (including spontaneous nasal
regurgitation), voice changes, and disturbances of
smell and taste. Up to 22% regretted having surgery.
An additional meta-analysis evaluated 18 surgical
studies (n=385; 17 level four audits, one randomised
controlled trial).7 Success, as measured by the number
of patients achieving a post-surgery apnoea/hypop-
noea index of 5 or less (a clinically significant standard
against which CPAP is judged), was limited.8 Pooled
success rates were 13% for phase I procedures
including uvulopalatopharyngoplasty (14 studies,
n=347) and 43% for phase II procedures including
osteotomies (four studies, n=38).
Barriers to change
Conservative weight management is recommended as
an adjunctive treatment, as it tackles a primary risk
factor for obstructive sleep apnoea (on the basis of two
randomised trials, combined n=91, and two non-
randomised concurrently controlled studies, n=41).9
Weight loss and other lifestyle modification can be
difficult to achieve, however. CPAP also depends on
acceptance and adherence by patients; its benefits in
mild to moderate obstructive sleep apnoea seem
inconclusive,3 10 making surgical “cure” seem more
attractive. Furthermore, in Australia, such surgery is
mainly done in the private sector, which has different
incentive mechanisms from the public system. How-
ever, given the lack of clear benefit from surgery and
the potential for harm indicated by currently available
evidence, guidelines recommend CPAP as first line
treatment for obstructive sleep apnoea generally.2 3
WhenCPAP treatment fails,mandibular advancement
devicesmaybe considered (with conservativemanage-
ment) as second line treatment (16 randomised trials,
n=745).2 11
How should we change our practice?
CPAP remains the recommended first line treatment
for obstructive sleep apnoea in adults.2 3 10 Conserva-
tive weight management (as a primary risk factor) is
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Searchmethods
We searched Medline, the Cochrane Library, and the
International Network of Agencies for Health Technology
Assessment database. We selected randomised
controlled trials, systematic reviews, and practice
guidelines that assessed the safety and efficacy of upper
airway surgical procedures in the treatment of obstructive
sleep apnoea in adults. We did bibliometric searches of
identified articles, including our own published results,
and communicated with specialist surgeons and sleep
medicine physicians to identify relevant published
evidence.
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recommended as adjunctive treatment.9 When CPAP
treatment fails, mandibular advancement devices may
be considered (with conservative management) as
second line treatment.2 11 Surgery for obstructive
sleep apnoea should be done within controlled clinical
trials. Patients should be informed about the trial, as
well as of the inconsistent results of surgery, the
associated pain, the potential side effects, and the
potential for relapse.
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My first and best role model
As final year medical students, we had an obligatory two
weeks’ rotation in the hospital’s dermatology department.
Although we could appreciate how common, important,
and revealing skin problems were, dermatology was way
off the mainstream for us.
OuryoungAmericandermatology instructorbeckoned
me at the end of one morning session. “What does a
handsome young man like you need those for?” were his
exact words, indicating two moles that I had on my face.
He undertook to remove them forme, explaining that this
could be easily done and would not take more than a few
minutes.
I was taken by surprise. I never gave it a thought before.
The moles were just there, just as my nose was, although
theywerequitedisturbing—one abovemy left eye, and the
other in the middle of my right cheek. The dermatology
instructor’s empathy and enthusiasm were catching,
however. When I stalled a bit, he was encouraging but
neither pressing nor offended, leaving me the option to
decide. Soon, I agreed wholeheartedly, and both moles
were removed in a matter of minutes by a shave biopsy
under local anaesthetic.
Soon, therewasno sign themoleshadever existed, and I
remain deeply grateful tomy instructor,whom Inever saw
again. I felt so much better afterwards, that I seriously
believe that my self image improved and even my dating
and falling in love with my future wife was a direct
consequenceofmyshort sojourn indermatology that year.
Now, as a member of the faculty in the same medical
school where I used to be a student, I often think of the
essential subtle ingredients of the much discussed
doctor-patient relationship. I realise that my dermatology
instructor was the perfect embodiment of the best
physician—observant (or he would not have noticed two
smallmoles in a class of 10 students), keen to recognise and
easy to appreciate the best in his patient (I was a much
loved only son, but this was the first time that anyone had
said Iwashandsome), sensitiveandwith insight (beingable
to see things from the other’s point of view and sense how
potentially noxious those moles really were), taking the
lead and showing authority (not hesitating to take the
initiative and point out the best solution), committed (not
minding the extra work and responsibility involved, nor
the total lack of any reward), and highly professional
(impeccably performing the operation and follow-up).
I hope hemay read this, as the smallest of tokens that he
deserves. He remains my first and best role model and a
symbol of how exemplary physicians affect the lives of
their patients.
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